Deep brain stimulation (DBS) is a promising intervention for treatment-resistant psychiatric
disorders, particularly major depressive disorder (MDD) and obsessive-compulsive disorder …

Introduction: Epilepsy affects more than 1% of the US population, and over 30% of adults
with epilepsy do not respond to antiseizure medications without life-impacting medication …

Employing hardware accelerators to improve the performance and energy-efficiency of DNN
applications is on the rise. One challenge of using hardware accelerators, including the GPU …

We estimate that 208,000 deep brain stimulation (DBS) devices have been implanted to
address neurological and neuropsychiatric disorders worldwide. DBS Think Tank presenters …

Deep brain stimulation (DBS) is an invasive approach to precise modulation of
psychiatrically relevant circuits. Although it has impressive results in open-label psychiatric …

Objective. To provide a design analysis and guidance framework for the implementation of
concurrent stimulation and sensing during adaptive deep brain stimulation (aDBS) with …

Epilepsy is the fourth most common neurological disorder, but current treatment options
provide limited efficacy and carry the potential for problematic adverse effects. There is an …

Neural stimulation can alleviate paralysis and sensory deficits. Novel high-density neural
interfaces can enable refined and multipronged neurostimulation interventions. To achieve …

Additional treatment options for temporal lobe epilepsy are needed, and potential
interventions targeting the cerebellum are of interest. Previous animal work has shown …

Approximately 1 in 26 people will develop epilepsy in their lifetime, but current treatment
options leave as many as half of all epilepsy patients with uncontrolled seizures. In addition …